Dr. Lal Path Labs Ltd. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.134x

Dr. Lal Path Labs Ltd. cash flow conversion efficiency. Based on the latest financial reports, Dr. Lal Path Labs Ltd. (LALPATHLAB) has a cash flow conversion efficiency ratio of 0.134x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.24 Billion ≈ $35.04 Million USD) by net assets (Rs24.22 Billion ≈ $261.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dr. Lal Path Labs Ltd. (2011–2026)

Cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2026. This chart illustrates how Dr. Lal Path Labs Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Dr. Lal Path Labs Ltd. for real-time trading data and today's change.

Dr. Lal Path Labs Ltd. Cash Flow Conversion Ratio Explained

Dr. Lal Path Labs Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dr. Lal Path Labs Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Lal Path Labs Ltd. ranked by their cash flow conversion efficiency. Also see Dr. Lal Path Labs Ltd. stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Viking Therapeutics Inc
NASDAQ:VKTX
-0.307x
Hangzhou EZVIZ Network Co. Ltd. A
SHG:688475
N/A
Jason Furniture(Hangzhou)
SHG:603816
0.071x
Skeena Resources Ltd
TO:SKE
-0.084x
Apeloa Pharmaceutical Co Ltd
SHE:000739
0.068x
Xiamen Faratronic Co Ltd
SHG:600563
0.036x
GRAIL, LLC
NASDAQ:GRAL
-0.032x
Gentera S.A.B. de C.V
MX:GENTERA
0.097x

Annual Cash Flow Conversion Efficiency for Dr. Lal Path Labs Ltd. (2011–2026)

The table below shows the annual cash flow conversion efficiency of Dr. Lal Path Labs Ltd. from 2011 to 2026. Review Dr. Lal Path Labs Ltd. free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs25.41 Billion
≈ $274.83 Million
Rs7.02 Billion
≈ $75.92 Million
0.276x +7.16%
2025-03-31 Rs22.07 Billion
≈ $238.62 Million
Rs5.69 Billion
≈ $61.51 Million
0.258x -9.21%
2024-03-31 Rs18.85 Billion
≈ $203.89 Million
Rs5.35 Billion
≈ $57.89 Million
0.284x +5.82%
2023-03-31 Rs17.00 Billion
≈ $183.79 Million
Rs4.56 Billion
≈ $49.31 Million
0.268x -7.28%
2022-03-31 Rs15.44 Billion
≈ $166.93 Million
Rs4.47 Billion
≈ $48.31 Million
0.289x -7.25%
2021-03-31 Rs12.76 Billion
≈ $138.00 Million
Rs3.98 Billion
≈ $43.06 Million
0.312x +15.85%
2020-03-31 Rs10.54 Billion
≈ $113.99 Million
Rs2.84 Billion
≈ $30.70 Million
0.269x +17.20%
2019-03-31 Rs9.51 Billion
≈ $102.84 Million
Rs2.19 Billion
≈ $23.63 Million
0.230x -7.30%
2018-03-31 Rs7.95 Billion
≈ $85.97 Million
Rs1.97 Billion
≈ $21.31 Million
0.248x -4.36%
2017-03-31 Rs6.62 Billion
≈ $71.61 Million
Rs1.72 Billion
≈ $18.56 Million
0.259x -10.07%
2016-03-31 Rs5.10 Billion
≈ $55.10 Million
Rs1.47 Billion
≈ $15.88 Million
0.288x +1.14%
2015-03-31 Rs3.43 Billion
≈ $37.14 Million
Rs978.50 Million
≈ $10.58 Million
0.285x -32.12%
2014-03-31 Rs2.33 Billion
≈ $25.23 Million
Rs979.58 Million
≈ $10.59 Million
0.420x -22.03%
2013-03-31 Rs1.64 Billion
≈ $17.70 Million
Rs881.31 Million
≈ $9.53 Million
0.538x -7.47%
2012-03-31 Rs1.17 Billion
≈ $12.66 Million
Rs681.28 Million
≈ $7.37 Million
0.582x +30.20%
2011-03-31 Rs934.94 Million
≈ $10.11 Million
Rs417.87 Million
≈ $4.52 Million
0.447x --

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research
Market Cap
$3.41 Billion
Rs315.12 Billion INR
Market Cap Rank
#4409 Global
#193 in India
Share Price
Rs1887.20
Change (1 day)
-1.01%
52-Week Range
Rs1307.60 - Rs3208.10
All Time High
Rs4119.53
About

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomi… Read more